Payden & Rygel Investment Group Abbott Laboratories Transaction History
Payden & Rygel Investment Group
- $2.12 Billion
- Q1 2024
A detailed history of Payden & Rygel Investment Group transactions in Abbott Laboratories stock. As of the latest transaction made, Payden & Rygel Investment Group holds 133,500 shares of ABT stock, worth $13.8 Million. This represents 0.72% of its overall portfolio holdings.
Number of Shares
133,500
Previous 112,590
18.57%
Holding current value
$13.8 Million
Previous $10.9 Million
39.16%
% of portfolio
0.72%
Previous 0.74%
Shares
2 transactions
Others Institutions Holding ABT
# of Institutions
3,129Shares Held
1.29BCall Options Held
8.43MPut Options Held
8.71M-
Vanguard Group Inc Valley Forge, PA165MShares$17.1 Billion0.38% of portfolio
-
Black Rock Inc. New York, NY133MShares$13.7 Billion0.36% of portfolio
-
Capital Research Global Investors Los Angeles, CA84MShares$8.67 Billion2.23% of portfolio
-
State Street Corp Boston, MA74.7MShares$7.71 Billion0.39% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$7.24 Billion1.65% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $181B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...